[Home ] [Archive]   [ فارسی ]  
:: Main :: About :: Current Issue :: Archive :: Search :: Submit :: Contact ::
Main Menu
Home::
Journal Information::
Articles archive::
For Authors::
For Reviewers::
Registration::
Contact us::
Site Facilities::
Webmail::
::
Search in website

Advanced Search
..
Receive site information
Enter your Email in the following box to receive the site news and information.
..
:: Volume 23, Issue 1 (Spring 2013) ::
MEDICAL SCIENCES 2013, 23(1): 1-6 Back to browse issues page
Effect of pentoxifylline on hepatocytes' damages due to administration of ecstasy in Wistar rat
Alieh Karimi1 , Shabnam Movassaghi2 , Zahra Nadia Sharifi2 , Mansooreh Soleimani3 , Hamed Shafaroodi4 , Mehrdad Hashemi 5
1- MSc of Cellular and Molecular Biology, Islamic Azad University, Pharmaceutical Sciences Branch, Tehran, Iran
2- Department of Anatomy, Faculty of Medicine, Islamic Azad University, Tehran Medical Branch, Tehran, Iran
3- Cellular and Molecular Research Center, Faculty of Medicine, Tehran University of Medical Sciences, Tehran, Iran
4- Department of Pharmacology, Islamic Azad University, Pharmaceutical Sciences Branch, Tehran, Iran
5- Department of Genetic, Faculty of Biology, Islamic Azad University, Tehran Medical Branch, Tehran, Iran , hashemi_mehrdad@yahoo.com
Abstract:   (12699 Views)
Background: Ecstasy is a psychoactive, hallucinogen drug and a member of amphetamines family and is used commonly worldwide. Ecstasy overdose leads to restlessness, anxiety, hallucination, cardiovascular disorders and liver toxicity. Recently, the use of vasodilators, such as pentoxifylline (PTX), is one of the new strategies for protection against liver lesions caused by some substances such as alcohol consumption. There are few studies about the protective effect of pentoxifylline on liver damages due to MDMA long administration. Therefore, a comprehensive study on the protective effect of pentoxifylline on liver lesions caused by prolonged use of ecstasy seems to be necessary.
Materials and methods: This experimental study was performed on five groups: control, Ecstasy (7.5 mg/kg), Experimental 1 (100 mg/kg PTX simultaneously with the last dose of Ecstasy), experimental 2 (100 mg/kg PTX a week before Ecstasy injection), and vehicle (normal saline) groups (n=25). After two weeks, animals were killed and their livers were prepared for histological studies (H&E method) and TUNEL technique for investigating of apoptotic bodies.
Results: The apoptotic bodies and hepatocytes lesions in experimental group 1 were lower than the other groupsm except control.
Conclusion: It seems that the use of pentoxifylline after consumption of pure ecstasy can decrease tissue damage and prevent the induction of apoptosis in rat liver.
Keywords: Ecstasy, Pentoxifylline, Hepatocyte, Liver, Apoptosis
Full-Text [PDF 828 kb]   (2714 Downloads)    
Semi-pilot: Experimental | Subject: Biology
Received: 2013/03/16 | Accepted: 2013/05/28 | Published: 2013/05/28
Send email to the article author

Add your comments about this article
Your username or Email:

CAPTCHA


XML   Persian Abstract   Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Karimi A, Movassaghi S, Sharifi Z N, Soleimani M, Shafaroodi H, Hashemi M. Effect of pentoxifylline on hepatocytes' damages due to administration of ecstasy in Wistar rat . MEDICAL SCIENCES 2013; 23 (1) :1-6
URL: http://tmuj.iautmu.ac.ir/article-1-646-en.html


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Volume 23, Issue 1 (Spring 2013) Back to browse issues page
فصلنامه علوم پزشکی دانشگاه آزاد اسلامی واحد پزشکی تهران Medical Science Journal of Islamic Azad Univesity - Tehran Medical Branch
Persian site map - English site map - Created in 0.05 seconds with 37 queries by YEKTAWEB 4645